Ceribell Inc (CBLL)

$20.93 +0.52 (2.55%)
Market Cap 776.42M
Revenue (ttm) 65.44M
Net Income (ttm) -40.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -61.83%
Debt to Equity Ratio 0.12
Volume 332,300
Avg Vol 419,458
Day's Range N/A - N/A
Shares Out 37.10M
Stochastic %K 57%
Beta 1.35
Analysts Strong Sell
Price Target $27.00

Company Profile

CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders...

Industry: Medical Devices
Sector: Healthcare
Phone: 800 436 0826
Address:
360 North Pastoria Avenue, Sunnyvale, United States
ZacksResearch
ZacksResearch Dec. 12 at 4:46 PM
Huge win for $CBLL — FDA just greenlit a truly unique delirium monitoring solution. That clearance strengthens its AI-driven EEG platform and pushes the company deeper into critical care, expanding its footprint where accuracy really matters. Full breakdown here 👉 https://www.zacks.com/stock/news/2803767/cbll-gets-fda-consent-for-one-of-a-kind-delirium-monitoring-solution?cid=sm-stocktwits-2-2803767-teaser-24681&ADID=SYND_STOCKTWITS_TWEET_2_2803767_TEASER_24681
0 · Reply
ZacksResearch
ZacksResearch Dec. 12 at 3:46 PM
FDA clearance for $CBLL's new technology — why is the stock down? 🤔 Despite being the first FDA-cleared solution for continuous delirium monitoring, shares have dropped 3.8% since Wednesday and are down 21.1% YTD. This AI-driven system could revolutionize brain care in ICUs, but investors seem wary. Discover the potential impact and what's next for CBLL 👉 https://www.zacks.com/stock/news/2803767/cbll-gets-fda-consent-for-one-of-a-kind-delirium-monitoring-solution?cid=sm-stocktwits-2-2803767-body-24660&ADID=SYND_STOCKTWITS_TWEET_2_2803767_BODY_24660
0 · Reply
Sigh_why
Sigh_why Dec. 9 at 2:35 PM
$CBLL 90% up in a month sheesh
1 · Reply
RockyTSTH
RockyTSTH Dec. 9 at 2:19 PM
$CBLL CeriBell shares are trading higher after the company announced it received FDA 510(k) clearance for its proprietary delirium monitoring solution.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 5 at 10:59 PM
$CBLL Share Price: $19.74 Contract Selected: Jun 18, 2026 $20 Calls Buy Zone: $1.53 – $1.89 Target Zone: $2.58 – $3.15 Potential Upside: 59% ROI Time to Expiration: 194 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Muhammediceland
Muhammediceland Dec. 4 at 5:15 PM
$LCID While mostly talking about Lucid, I have +20 more stocks in my portfolio. And oh man oh man. I sold all my profiting $CBLL shares and put them in $ALVO . Alvotech literally has its headquarter around 100 meters from my PhD desk. Brand new building and you can see right through the windows; all the sophisticated stuff they are doing - or at least some of it haha. Already big profit... Let's go!
0 · Reply
Childishfanbino
Childishfanbino Dec. 1 at 2:44 AM
$CBLL
0 · Reply
Childishfanbino
Childishfanbino Nov. 26 at 12:58 AM
$CBLL am I the only one here? What a run
1 · Reply
StockScanners
StockScanners Nov. 25 at 4:41 AM
$CBLL reached 16
0 · Reply
topstockalerts
topstockalerts Nov. 24 at 3:26 PM
CeriBell announced FDA clearance for its AI-powered neonatal seizure-detection algorithm, making its system the first point-of-care EEG with AI capable of identifying electrographic seizures across all ages, from premature infants to adults. The technology targets a major gap in neonatal care: while about 9% of NICU patients have seizures, research shows up to 90% go undetected without EEG monitoring, and prolonged seizures greatly increase risks of mortality and long-term disability. CEO Jane Chao said protecting newborns’ fragile brains is critical for long-term outcomes. The FDA decision was supported by EEG data from over 700 patients—the largest validation dataset for neonatal seizure detection. CeriBell previously received clearance for a neonatal-specific EEG headset. The system aims to enable real-time detection of non-convulsive seizures to support faster diagnosis and treatment. $CBLL
0 · Reply
Latest News on CBLL
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution

Dec 9, 2025, 8:00 AM EST - 5 days ago

Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

Nov 24, 2025, 8:00 AM EST - 20 days ago

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 4:05 PM EST - 24 days ago

Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Nov 6, 2025, 4:05 PM EST - 5 weeks ago

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

CeriBell, Inc. (CBLL) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 9:46 PM EST - 5 weeks ago

CeriBell, Inc. (CBLL) Q3 2025 Earnings Call Transcript

Ceribell Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 4:05 PM EST - 5 weeks ago

Ceribell Reports Third Quarter 2025 Financial Results

Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025

Oct 21, 2025, 4:05 PM EDT - 7 weeks ago

Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025

Medtech Leader Erica Rogers Joins Ceribell Board of Directors

Sep 22, 2025, 8:00 AM EDT - 2 months ago

Medtech Leader Erica Rogers Joins Ceribell Board of Directors

CeriBell (CBLL) Q2 Revenue Jumps 38%

Aug 6, 2025, 2:52 PM EDT - 4 months ago

CeriBell (CBLL) Q2 Revenue Jumps 38%

CeriBell, Inc. (CBLL) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 11:44 PM EDT - 4 months ago

CeriBell, Inc. (CBLL) Q2 2025 Earnings Call Transcript

Ceribell Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 4:05 PM EDT - 4 months ago

Ceribell Reports Second Quarter 2025 Financial Results

Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025

Jul 22, 2025, 4:05 PM EDT - 5 months ago

Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware

Jul 7, 2025, 4:42 PM EDT - 5 months ago

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

May 20, 2025, 4:05 PM EDT - 7 months ago

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

CeriBell, Inc. (CBLL) Q1 2025 Earnings Call Transcript

May 10, 2025, 12:39 PM EDT - 7 months ago

CeriBell, Inc. (CBLL) Q1 2025 Earnings Call Transcript

Ceribell Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 7 months ago

Ceribell Reports First Quarter 2025 Financial Results

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

Apr 30, 2025, 4:05 PM EDT - 8 months ago

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems

Apr 30, 2025, 8:00 AM EDT - 8 months ago

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 4:05 PM EDT - 8 months ago

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

FDA Clears Ceribell's Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

Apr 15, 2025, 8:00 AM EDT - 8 months ago

FDA Clears Ceribell's Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

CeriBell, Inc. (CBLL) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 8:38 AM EST - 10 months ago

CeriBell, Inc. (CBLL) Q4 2024 Earnings Call Transcript

Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 4:05 PM EST - 10 months ago

Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results

CeriBell: A Leader In AI-Powered Seizure Detection

Feb 21, 2025, 12:09 PM EST - 10 months ago

CeriBell: A Leader In AI-Powered Seizure Detection

Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference

Feb 18, 2025, 4:05 PM EST - 10 months ago

Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference

Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Feb 11, 2025, 4:05 PM EST - 10 months ago

Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 23, 2024, 4:05 PM EST - 1 year ago

Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

CeriBell: Healthcare Technology Stock With A Promising Growth Outlook

Nov 20, 2024, 7:00 AM EST - 1 year ago

CeriBell: Healthcare Technology Stock With A Promising Growth Outlook

Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024

Oct 29, 2024, 4:05 PM EDT - 1 year ago

Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024

CeriBell: An Interesting EEG Play Going Public

Oct 21, 2024, 6:07 AM EDT - 1 year ago

CeriBell: An Interesting EEG Play Going Public

New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG

Oct 16, 2024, 4:05 PM EDT - 1 year ago

New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG

CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Oct 15, 2024, 5:00 PM EDT - 1 year ago

CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

CeriBell IPO: Stock price will be closely watched today as the AI brain-monitoring headband maker debuts on the Nasdaq

Oct 11, 2024, 5:01 PM EDT - 1 year ago

CeriBell IPO: Stock price will be closely watched today as the AI brain-monitoring headband maker debuts on the Nasdaq

Ceribell's stock indicates up 35% in trading debut after pricing IPO at top of range

Oct 11, 2024, 12:03 PM EDT - 1 year ago

Ceribell's stock indicates up 35% in trading debut after pricing IPO at top of range

CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering

Oct 10, 2024, 11:27 PM EDT - 1 year ago

CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering

ZacksResearch
ZacksResearch Dec. 12 at 4:46 PM
Huge win for $CBLL — FDA just greenlit a truly unique delirium monitoring solution. That clearance strengthens its AI-driven EEG platform and pushes the company deeper into critical care, expanding its footprint where accuracy really matters. Full breakdown here 👉 https://www.zacks.com/stock/news/2803767/cbll-gets-fda-consent-for-one-of-a-kind-delirium-monitoring-solution?cid=sm-stocktwits-2-2803767-teaser-24681&ADID=SYND_STOCKTWITS_TWEET_2_2803767_TEASER_24681
0 · Reply
ZacksResearch
ZacksResearch Dec. 12 at 3:46 PM
FDA clearance for $CBLL's new technology — why is the stock down? 🤔 Despite being the first FDA-cleared solution for continuous delirium monitoring, shares have dropped 3.8% since Wednesday and are down 21.1% YTD. This AI-driven system could revolutionize brain care in ICUs, but investors seem wary. Discover the potential impact and what's next for CBLL 👉 https://www.zacks.com/stock/news/2803767/cbll-gets-fda-consent-for-one-of-a-kind-delirium-monitoring-solution?cid=sm-stocktwits-2-2803767-body-24660&ADID=SYND_STOCKTWITS_TWEET_2_2803767_BODY_24660
0 · Reply
Sigh_why
Sigh_why Dec. 9 at 2:35 PM
$CBLL 90% up in a month sheesh
1 · Reply
RockyTSTH
RockyTSTH Dec. 9 at 2:19 PM
$CBLL CeriBell shares are trading higher after the company announced it received FDA 510(k) clearance for its proprietary delirium monitoring solution.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 5 at 10:59 PM
$CBLL Share Price: $19.74 Contract Selected: Jun 18, 2026 $20 Calls Buy Zone: $1.53 – $1.89 Target Zone: $2.58 – $3.15 Potential Upside: 59% ROI Time to Expiration: 194 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Muhammediceland
Muhammediceland Dec. 4 at 5:15 PM
$LCID While mostly talking about Lucid, I have +20 more stocks in my portfolio. And oh man oh man. I sold all my profiting $CBLL shares and put them in $ALVO . Alvotech literally has its headquarter around 100 meters from my PhD desk. Brand new building and you can see right through the windows; all the sophisticated stuff they are doing - or at least some of it haha. Already big profit... Let's go!
0 · Reply
Childishfanbino
Childishfanbino Dec. 1 at 2:44 AM
$CBLL
0 · Reply
Childishfanbino
Childishfanbino Nov. 26 at 12:58 AM
$CBLL am I the only one here? What a run
1 · Reply
StockScanners
StockScanners Nov. 25 at 4:41 AM
$CBLL reached 16
0 · Reply
topstockalerts
topstockalerts Nov. 24 at 3:26 PM
CeriBell announced FDA clearance for its AI-powered neonatal seizure-detection algorithm, making its system the first point-of-care EEG with AI capable of identifying electrographic seizures across all ages, from premature infants to adults. The technology targets a major gap in neonatal care: while about 9% of NICU patients have seizures, research shows up to 90% go undetected without EEG monitoring, and prolonged seizures greatly increase risks of mortality and long-term disability. CEO Jane Chao said protecting newborns’ fragile brains is critical for long-term outcomes. The FDA decision was supported by EEG data from over 700 patients—the largest validation dataset for neonatal seizure detection. CeriBell previously received clearance for a neonatal-specific EEG headset. The system aims to enable real-time detection of non-convulsive seizures to support faster diagnosis and treatment. $CBLL
0 · Reply
StockScanners
StockScanners Nov. 23 at 2:37 AM
$CBLL keep watch if this holds above 15
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 7:51 PM
JP Morgan has updated their rating for CeriBell ( $CBLL ) to Overweight with a price target of 17.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 6:43 PM
TD Cowen has updated their rating for CeriBell ( $CBLL ) to Buy with a price target of 20.
0 · Reply
d_risk
d_risk Nov. 4 at 10:37 PM
$CBLL - Ceribell, Inc. - 10Q - Updated Risk Factors CBLL’s 10-Q risk factors spotlight ongoing losses, heavy reliance on Ceribell System adoption, fierce competition from legacy EEG players, supply chain and China trade risks, AI innovation pressures, and new threats from tariffs, government shutdowns, and alternative technologies. #MedicalDevices #TradeTariffs #CompetitivePressure #SupplyChainRisk #AIInnovation 🟢 Added 🟠 Removed https://d-risk.ai/CBLL/10-Q/2025-11-04
0 · Reply
RocketThief
RocketThief Oct. 31 at 5:55 PM
$CBLL small buy, not going too heavy before earnings
1 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 5:39 PM
Raymond James has updated their rating for CeriBell ( $CBLL ) to Strong Buy with a price target of 19.
0 · Reply
belugatrade
belugatrade Oct. 8 at 5:23 PM
$CBLL in a gorgeous consolidation mode now. I expect a move up from here. Stop under $11.80
0 · Reply
CH_Expat
CH_Expat Oct. 8 at 12:31 PM
$CBLL @RocketThief Getting closer...
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Oct. 7 at 12:32 AM
$CBLL 🤔
1 · Reply
tommyrulz
tommyrulz Oct. 3 at 3:49 PM
$CBLL anyone know why all the sudden love today??
1 · Reply
RocketThief
RocketThief Oct. 3 at 3:16 PM
$CBLL will buy in again in mid-11s
0 · Reply
RocketThief
RocketThief Sep. 12 at 2:58 PM
$CBLL bought in again
0 · Reply